isoflurophate has been researched along with Hepatic Encephalopathy in 1 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)
Excerpt | Relevance | Reference |
---|---|---|
"Portacaval shunting is a model for hepatic encephalopathy that causes chronic hyperammonemia, disruption of metabolic, signaling, and neurotransmitter systems, and progressive morphological changes." | 1.40 | Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats. ( Cruz, NF; Dienel, GA, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dienel, GA | 1 |
Cruz, NF | 1 |
1 other study available for isoflurophate and Hepatic Encephalopathy
Article | Year |
---|---|
Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats.
Topics: Amino Acids; Animals; Fluorescent Dyes; Hepatic Encephalopathy; Hydrogen-Ion Concentration; Hyperamm | 2014 |